Evidence map›Paper›PMID 25881876›Full record

ArticleFertility and sterility2015

Optimal timing for elective egg freezing.

Tolga B Mesen, Jennifer E Mersereau, Jennifer B Kane, Anne Z Steiner

Registry-linked trialAbstract read
In one paragraph

Article in Fertility and sterility, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07225660 (A Randomized Blinded Controlled Trial Assessing Hormonal Optimization), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07225660 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized Blinded Controlled Trial Assessing Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)

TypeinterventionalSponsorShady Grove Fertility Reproductive Science CenterRan2026 to 2027Enrolled394ConditionsFertility PreservationArmsOCP pause
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Social Freezing: Pressing Pause on Fertility.International journal of environmental research and public health · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Reproduction reimagined.F&S reports · 2021
    Article
  15. Article
  16. Article
  17. Elective oocyte cryopreservation for age-related fertility decline.Journal of assisted reproduction and genetics · 2021
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tolga B MesenDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina. Electronic address: tolga_mesen@med.unc.edu.
Jennifer E MersereauDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina.
Jennifer B KaneCarolina Population Center, University of North Carolina, Chapel Hill, North Carolina.
Anne Z SteinerDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina.

Funding

POPULATION STUDIEST32HD007168 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ELIZABETH A FRANKENBERG · 1985 to 2026
$13.8M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Time to ConceiveR21HD060229 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STEINER, ANNE ZWEIFEL · 2009 to 2010
$407k
The Maternal Life Course Origins of Infant HealthK99HD075860 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUHER-KANE, JENNIFER · 2014 to 2015
$162k
NICHD NIH HHS K99 HD075860NICHD NIH HHS P2C HD050924NICHD NIH HHS R21 HD060229NICHD NIH HHS T32 HD007168PHS HHS R01067683
6 · The paper itself

Abstract

objectiveTo estimate the optimal age to pursue elective oocyte cryopreservation.

designA decision-tree model was constructed to determine the success and cost-effectiveness of oocyte preservation versus no action when considered at ages 25-40 years, assuming an attempt at procreation 3, 5, or 7 years after initial decision.

settingNot applicable. PATIENT(S): Hypothetical patients 25-40 years old presenting to discuss elective oocyte cryopreservation. INTERVENTION(S): Decision to cryopreserve oocytes from age 25 years to age 40 years versus taking no action. MAIN OUTCOME AND MEASURE(S): Probability of live birth after initial decision whether or not to cryopreserve oocytes. RESULT(S): Oocyte cryopreservation provided the greatest improvement in probability of live birth compared with no action (51.6% vs. 21.9%) when performed at age 37 years. The highest probability of live birth was seen when oocyte cryopreservation was performed at ages <34 years (>74%), although little benefit over no action was seen at ages 25-30 years (2.6%-7.1% increase). Oocyte cryopreservation was most cost-effective at age 37 years, at $28,759 per each additional live birth in the oocyte cryopreservation group. When the probability of marriage was included, oocyte cryopreservation resulted in little improvement in live birth rates. CONCLUSION(S): Oocyte cryopreservation can be of great benefit to specific women and has the highest chance of success when performed at an earlier age. At age 37 years, oocyte cryopreservation has the largest benefit over no action and is most cost-effective.

Indexed as

AdultAge DistributionCell SurvivalCost-Benefit AnalysisCryopreservationDecision Support TechniquesFemaleFertility PreservationFertilization in VitroHealth Care CostsHumansInfertility, FemaleLive BirthNorth CarolinaOocyte RetrievalPregnancyegg freezingElective oocyte cryopreservationfertility preservation

Identifiers

PMID25881876
PMCPMC4457646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.